Along with appetite control, semaglutide supports steady blood sugar levels, which helps the body use energy more efficiently
The incidence of side effects in the Lcarnitine group was significantly higher than in the placebo group (18% vs 4%, P = 0.025)
Yet, while their ability to reduce body weight and insulin levels was greater than GLP1 monotherapy in male models 33,34,35 , the potential of these GLP1-based multi-agonists for the treatment of the metabolic, hormonal, and gonadal complications associated with PCOS has not been explored to date
While individual results vary, GLP-1 medications have been studied for their ability to: Help regulate blood sugar levels Influence appetite regulation Support sustained lifestyle changes For instance, a 68-week clinical trial found that participants taking semaglutide along with lifestyle intervention had significantly greater improvements compared to placebo